Charlotte Elisabet Edenius
Director/Board Member at KANCERA AB
Network origin in Charlotte Elisabet Edenius first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
29
| Public Company | Pharmaceuticals: Major | 29 |
15
| Public Company | Pharmaceuticals: Major | 15 |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charlotte Elisabet Edenius via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Chief Executive Officer Director/Board Member Chairman | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VITROLIFE AB | Medical Specialties | Director/Board Member General Counsel | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| OREXO AB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer General Counsel | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| University of Stockholm | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Investor Relations Contact | |
| CAMURUS AB | Pharmaceuticals: Major | Investor Relations Contact General Counsel | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The Swedish Bar Association | Corporate Officer/Principal Corporate Officer/Principal | ||
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| Pfizer AB | Chief Executive Officer Sales & Marketing | ||
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Founder Corporate Officer/Principal | |
| OxyPharma AB | Director/Board Member Director/Board Member Chairman | ||
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| STENDÖRREN FASTIGHETER AB | Real Estate Development | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Operating Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Blasieholmen Investment Group AB | Director/Board Member Director/Board Member | ||
| SALTX TECHNOLOGY HOLDING AB | Electronic Production Equipment | Chairman Chief Executive Officer | |
| NICOCCINO HOLDING AB | Tobacco | Director/Board Member Director of Finance/CFO | |
| KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| KLARIA PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
| G. Pettersson & Partners AB | Director/Board Member Director/Board Member | ||
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Medivir Personal AB | Director/Board Member Director/Board Member Director/Board Member | ||
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistics
International
| Sweden | 47 |
| United States | 3 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 9 |
| Finance | 4 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 374 |
| Chairman | 126 |
| Corporate Officer/Principal | 117 |
| Independent Dir/Board Member | 73 |
| Chief Executive Officer | 53 |
Most connected contacts
- Stock Market
- Insiders
- Charlotte Elisabet Edenius
- Company connections
